Patents by Inventor Martin Mansson

Martin Mansson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10640536
    Abstract: Disclosed herein is a composition comprising at least one polymyxin or a salt thereof represented by formula (I) wherein R1 is an aliphatic linear or branched C6-C10 acyl group, or (I?) R5 is —CH(CH3)2, —CH2CH(CH3)2, —CH(CH3)CH2CH3, or —CH2C6H5; R6 is —CH(CH3)2, —CH2CH(CH3)2, or —CH(CH3)CH2CH3; each of R2, R3, R4, R7 and R8 is either —(CH2)xCH2NH2 or —(CH2)xCH2N(CH2SO3M)2; wherein x is 0 or 1; wherein M is a monovalent cation; and wherein at least three of R2, R3, R4, R7 and R8 are —(CH2)xCH2N(CH2SO3M)2.
    Type: Grant
    Filed: January 9, 2014
    Date of Patent: May 5, 2020
    Assignee: XELLIA PHARMACEUTICALS APS
    Inventors: Solvi Gunnes, Vidar Bjornstad, Torben Koch, Claes Melander, Martin Mansson
  • Publication number: 20200008170
    Abstract: There is provided mechanisms for locating wireless devices. A method is performed by a network operator node of cells. The method comprises obtaining an indication to locate wireless devices in a geographical area from a surveillance center node (s102). The method comprises initiating a change of logical group area identity of those of its cells that at least partly overlap with the geographical area (s104), thereby initiating location reporting from those wireless devices located in the geographical area that are in idle mode. The method comprises, in response thereto, receiving location indicating information from the wireless devices in the geographical area (s106).
    Type: Application
    Filed: February 16, 2017
    Publication date: January 2, 2020
    Inventors: Rickard Evertsson, Martin Klitte, Staffan Månsson, Ali Nader
  • Patent number: 9272983
    Abstract: The present invention concerns 2-amino-3-methyl-hex-5-enoic acid, its use for the production of peptides such as bacitracins and a method for producing it.
    Type: Grant
    Filed: September 30, 2010
    Date of Patent: March 1, 2016
    Assignee: XELLIA PHARMACEUTICALS APS
    Inventors: Martin Mansson, Christine Senstad, Jon Efskind, Vidar Bjornstad
  • Publication number: 20160031798
    Abstract: The present invention concerns 2-amino-3-mmethyl-hex-5-enoic acid, its use for the production of peptides such as bacitracins and a method for producing it.
    Type: Application
    Filed: September 9, 2015
    Publication date: February 4, 2016
    Inventors: Martin Mansson, Christine Senstad, Jon Efskind, Vidar Bjornstad
  • Publication number: 20160002296
    Abstract: Disclosed herein is a composition comprising at least one polymyxin or a salt thereof represented by formula (I) wherein R1 is an aliphatic linear or branched C6-C10 acyl group, or (I?) R5 is —CH(CH3)2, —CH2CH(CH3)2, —CH(CH3)CH2CH3, or —CH2C6H5; R6 is —CH(CH3)2, —CH2CH(CH3)2, or —CH(CH3)CH2CH3; each of R2, R3, R4, R7 and R8 is either —(CH2)XCH2NH2 or —(CH2)xCH2N(CH2SO3M)2; wherein x is 0 or 1; wherein M is a monovalent cation; and wherein at least three of R2, R3, R4, R7 and R are —(CH2)xCH2N(CH2SO3M)2.
    Type: Application
    Filed: January 9, 2014
    Publication date: January 7, 2016
    Inventors: SOLVI GUNNES, VIDAR BJORNSTAD, TORBEN KOCH, CLAES MELANDER, MARTIN MANSSON
  • Patent number: 9150894
    Abstract: The present invention relates to a process for purifying lipopeptides. More particular, the invention provides an improved method for purifying daptomycin.
    Type: Grant
    Filed: February 19, 2010
    Date of Patent: October 6, 2015
    Assignee: XELLIA PHARMACEUTICALS APS
    Inventors: Martin Mansson, Eli Karin Dale, Sissel Hauge, Carsten Overballe-Petersen, Kjersti Aastorp Hirth, Dennis Brian Hansen
  • Patent number: 8492707
    Abstract: The present invention concerns a method of detecting the antifungal cyclic hexapeptides Pneumocandin B0 and/or Pneumocandin C0 specific fragment is/are detected using MS in negative mode.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: July 23, 2013
    Assignee: Xellia Pharmaceuticals APS
    Inventors: Anders Brunsvik, Martin Mansson
  • Patent number: 8410044
    Abstract: The invention concerns new Bacitracin compounds containing methylene-isoleucine.
    Type: Grant
    Filed: September 30, 2010
    Date of Patent: April 2, 2013
    Assignee: Xellia Pharmaceuticals Aps
    Inventors: Martin Mansson, Christine Senstad
  • Publication number: 20120202968
    Abstract: The present invention concerns 2-amino-3-methyl-hex-5-enoic acid, its use for the production of peptides such as bacitracins and a method for producing it.
    Type: Application
    Filed: September 30, 2010
    Publication date: August 9, 2012
    Applicant: XELLIA PHARMACEUTICALS APS
    Inventors: Martin Mansson, Christine Senstad, Jon Efskind, Vidar Bjornstad
  • Publication number: 20120202737
    Abstract: The invention concerns new Bacitracin compounds containing methylene-isoleucine.
    Type: Application
    Filed: September 30, 2010
    Publication date: August 9, 2012
    Applicant: XELLIA PHARMACEUTICALS APS
    Inventors: Martin Mansson, Christine Senstad
  • Publication number: 20120138786
    Abstract: The present invention concerns a method of detecting the antifungal cyclic hexapeptides Pneumocandin B0 and/or Pneumocandin C0 specific fragment is/are detected using MS in negative mode.
    Type: Application
    Filed: August 11, 2010
    Publication date: June 7, 2012
    Applicant: XELLIA PHARMACEUTICALS APS
    Inventors: Anders Brunsvik, Martin Mansson
  • Publication number: 20100228006
    Abstract: The present invention relates to a process for purifying lipopeptides. More particular, the invention provides an improved method for purifying daptomycin.
    Type: Application
    Filed: February 19, 2010
    Publication date: September 9, 2010
    Applicant: AXELLIA PHARMACEUTICALS APS
    Inventors: Martin Mansson, Eli Karin Dale, Sissel Hauge, Carsten Overballe-Petersen, Kjersti Aastorp Hirth, Dennis Brian Hansen
  • Patent number: 7364739
    Abstract: The present invention relates to a lipopolysaccharide moiety comprising a conserved triheptosyl inner-core moiety of lipopolysaccharide substantially free of variable outer core oligosaccharide chain extension, and to vaccines obtaines therefrom which are cross-reactive for Haemophilus influenzae strains. The invention also relates to defined mutations in the biosynthetic machinery for lipopolysaccharide (LPS;) expression in Haemophilus influenzae useful to obtain the abovementioned moiety. The invention also relates to using conjugates of the LPS from the mutant strains so obtained to elicit a heterologous immune response against a wide range of disease-causing H. influenzae strains. More specifically, the invention relates to vaccines for prevention of bacterial infections comprising core lipopolysaccharide of Haemophilus influenzae.
    Type: Grant
    Filed: August 27, 2001
    Date of Patent: April 29, 2008
    Assignees: National Research Council of Canada, The Chancellor, Masters, and Scholars of the University of Oxford
    Inventors: James C. Richards, Andrew Cox, Richard Moxon, Derek Hood, Elke K. H. Schweda, Martin Månsson
  • Publication number: 20050153057
    Abstract: The present invention relates to a lipopolysaccharide moiety comprising a conserved triheptosyl inner-core moiety of lipopolysaccharide substantially free of variable outer core oligosaccharide chain extension, and to vaccines obtaines therefrom which are cross-reactive for Haemophilus influenzae strains. The invention also relates to defined mutations in the biosynthetic machinery for lipopolysaccharide (LPS;) expression in Haemophilus influenzae useful to obtain the abovementioned moiety. The invention also relates to using conjugates of the LPS from the mutant strains so obtained to elicit a heterologous immune response against a wide range of disease-causing H. influenzae strains. More specifically, the invention relates to vaccines for prevention of bacterial infections comprising core lipopolysaccharide of Haemophilus influenzae.
    Type: Application
    Filed: August 27, 2001
    Publication date: July 14, 2005
    Inventors: James Richards, Andrew Cox, Richard Moxon, Derek Hood, Elke Schweda, Martin Mansson
  • Patent number: 5331804
    Abstract: The present invention comprises an apparatus in a power plant having a combustion chamber for combustion of a fuel at overpressure, a turbine driven by generated combustion gases, a compressor driven by the turbine for compression of combustion air, a generator driven by the turbine and a gas conduit for transfer of combustion gases from the combustion chamber to the turbine, the apparatus including at least two start-up combustors located radially around the gas conduit, the start-up combustors being supplied upon the start-up with fuel and with combustion air from the compressor which in turn is rotated by the generator switched into motor operation. The start-up combustors deliver combustion gases to the turbine which, in turn, supplies power to the compressor.
    Type: Grant
    Filed: June 4, 1993
    Date of Patent: July 26, 1994
    Assignee: ABB Carbon AB
    Inventor: Martin Mansson
  • Patent number: 5330320
    Abstract: A method and a device for controlling the blade tip clearance in a rotating machine where the machine comprises a turbine part and a compressor part separate from the turbine part and the stator housing of the turbine part is formed with a stator cone. The invention is characterized in that one or more bladed turbine discs during a non-steady operation, such as start-up, stop and load changes, are moved out of the stator cone whereby the blade tip clearance is increased and that the turbine discs during continuous operation are moved into the stator cone such that the blade top clearance is reduced.
    Type: Grant
    Filed: March 31, 1993
    Date of Patent: July 19, 1994
    Assignee: ABB Carbon AB
    Inventor: Martin Mansson
  • Patent number: 4848276
    Abstract: A power plant utilizing combustion of fuel in a fluidized bed contains a particulate sulfur-absorbing material. A discharge device for bed material and ashes includes a crusher which breaks down the material so that it can be transported away or so that unconsumed absorbent in the bed material is exposed for reuse in the bed. The crusher has a stationary grinding portion and a rotating grinding portion receiving bed material. Scrapers selectively scrape off layers of material during rotation of the rotating grinding portion thus distributing the material around the periphery of the grinding portions.
    Type: Grant
    Filed: February 19, 1988
    Date of Patent: July 18, 1989
    Assignee: Asea Stal AB
    Inventors: Roine Brannstrom, Evert Lindblad, Leopold Malmkvist, Martin Mansson, Mats Thoren
  • Patent number: 4767315
    Abstract: The bed depth in a power plant burning sulfur-containing fuel in a fluidized bed of material which constitutes a sulfur absorbent in a combustion chamber is controlled on the basis of plant power output. A plurality of sensors connected to the combustion chamber determine the existing bed depth. A bed material mill grinds material removed from the bed prior to returning it to the bed, the rate at which the mill operates being controlled by the extent to which the actual bed depth differs from the desired bed depth. The mill grinds some bed material to small enough size for it to be carried from the combustion chamber with the combustion gases.
    Type: Grant
    Filed: October 10, 1986
    Date of Patent: August 30, 1988
    Assignee: Asea Stal Aktiebolag
    Inventors: Roine Brannstrom, Lars-Erik Karlsson, Martin Mansson
  • Patent number: 4655147
    Abstract: A plant for combustion of a particulate fuel in a fluidized bed in a combustion chamber has the fuel supplied into the bottom of the combustion chamber by means of a pneumatic transportation system via nozzles. Fuel for the plurality of nozzles is transported through a duct to a distributor and from there via individual conduits to the nozzles of the combustion chamber. These conduits include flow-inhibiting, pressure-drop generating means, by means of which a pressure drop is generated between the distributor and the combustion chamber. These pressure-drop inducing means influence the velocity of flow and hence the transport capacity of the transport gas so that a desired, normally uniform, distribution of fuel to the bed is secured.
    Type: Grant
    Filed: February 4, 1986
    Date of Patent: April 7, 1987
    Assignee: ASEA Stal AB
    Inventors: Roine Brannstrom, Martin Mansson
  • Patent number: 4245463
    Abstract: A gas turbine plant having an ignition combustion chamber for applying heated gas to heat the fluidized bed material to ignition temperature. In starting up the plant, a starter motor is employed to rotate a turbine and thereby to cause a compressor to produce compressed air. Liquid or gaseous fuel is applied to the ignition combustion chamber and is ignited within the chamber to heat compressed air from the compressor. The compressed air is passed through the fluidized bed combustor to heat the bed material up to ignition temperature. During the start-up operation, bed material in the fluidized bed combustor is reduced to reduce the pressure requirements for the heated compressed air.
    Type: Grant
    Filed: April 9, 1979
    Date of Patent: January 20, 1981
    Assignee: Stal-Laval Turbin AB
    Inventors: Martin Mansson, Ragnar Torstenfelt